Drugs / Hydrocodone-Acetaminophen
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02991261 | Feb → Mar 2017 | — | Sun Pharma Advanced Research Company Limited | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02958566 | Jan → Dec 2017 | colon carcinoma, constipation disorder, diverticulitis of colon, paralytic ileus +1 | University of Illinois College of Medicine at Peoria | Unknown | No outcome recorded |
| Comparator or background therapy6 trials | ||||||
| Phase 2 | NCT03818919 Comparator | Jan 2019 → Dec 2020 | rotator cuff syndrome | Henry Ford Health System | Completed | No outcome recorded |
| Phase 2/3 | NCT04939987 Comparator | Aug → Oct 2022 | — | Wake Forest University Health Sciences | Withdrawn | No outcome recorded |
| Phase 2/3 | NCT03818932 Comparator | Jan 2019 → Jan 2020 | — | Henry Ford Health System | Completed | Mixed |
| Phase 2/3 | NCT03825809 Comparator | Jan 2019 → Jan 2020 overdue | substance-related disorder | Henry Ford Health System | Recruiting | No outcome recorded |
| Phase 4 | NCT07037888 Background | Dec 2023 → Sep 2026 overdue | — | Henry Ford Health System | Recruiting | No outcome recorded |
| Phase 4 | NCT03121963 Comparator | Nov 2017 → Nov 2020 | — | University of Alabama at Birmingham | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hydrocodone-Acetaminophen | “hydrocodone-acetaminophen 5mg/325mg 1 tablet q6hrs PRN to start on POD0 30 tablets” NCT07037888 ↗7“Hydrocodone-acetaminophen” NCT02991261 ↗ |
| Route | Oral | “HYDROCODONE/ACETAMINOPHEN 5 Mg-325 Mg ORAL TABLET” NCT02958566 ↗ |